INSTITUTION'S PROFILE
Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Publications (1)
Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial.
Journal: The lancet. HIV
Publication date:
Journal: The lancet. HIV
Publication Year: